Personal Injury
Personal Injury Lawyer
For a free, confidential legal consultation, submit your Personal Injury injury claim or call 1-800-471-3980 now.
If you are looking for a firm that can handle Personal Injury lawsuits, or are simply unsure if you have a case, there is no obligation to discuss your case with one of GPW's attorneys. Contact us today.
About Personal Injury
February 28th, 2008. After six years, the U.S. Senate finally, and unanimously, passed Senator Patty Murray's Ban Asbestos in America Act last October. The act prohibits asbestos where present at more than 1% by weight, calls for a public education campaign about the dangers of asbestos exposure, and directs critically-needed federal research to ... [More >>]
January 31st, 2008. (Press Release) Working case definition for progressive inflammatory neuropathy among swine slaughterhouse workers, 2007–2008
Epidemiologic criterion
Participation in or close exposure to commercial or private swine-slaughtering operations.
Clinical criteria
... [More >>]
January 16th, 2008. (Press Release) The Minnesota Department of Health has learned that the Indiana Department of Health and CDC are investigating illnesses in several plant workers at a pig slaughtering plant in Indiana to determine if their illnesses are similar to what has been found in Minnesota.
MDH continues ... [More >>]
December 3rd, 2007. (Press Release) The Minnesota Department of Health (MDH) is investigating a cluster of 11 cases of neurological illness in workers at Quality Pork Processors, Inc. (QPP) in Austin, Minn.
QPP staff and physicians in the Austin and Rochester area recently realized there had been a pattern of cases of ... [More >>]
November 14th, 2007. (Press Release) The U.S. Food and Drug Administration announced today that the manufacturer of Avandia (rosiglitazone), a drug used to treat type 2 diabetes, has agreed to add new information to the existing boxed warning in the drug's labeling about potential increased risk for heart attacks.
People with type 2 diabetes who have ... [More >>]
October 24th, 2007. Distribution of two types of defibrillators, Implantable cardioverter defibrillators (ICDs) and Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds), is being suspended by Medtronic as a result of lead fractures. If a lead fractures, defibrillators may deliver unecessary shocks or may not function at all.
Issues with the leads was first ... [More >>]
October 22nd, 2007. (Press Release) Statement by Daniel Schultz, M.D., director of the Center for Devices and Radiological Health:
Medtronic's decision to voluntarily remove its Sprint Fidelis defibrillation leads from the market is in the best interest of patient safety.
These electronic wires are prone to fracture in a small number of patients which ... [More >>]
October 19th, 2007. (Press Release) On Monday, October 15, Medtronic, Inc. said voluntarily suspended worldwide distribution of the Sprint Fidelis® family of defibrillation leads because of the potential for lead fractures. In addition, the company recommends against new implants of the leads (Sprint Fidelis Models: 6930, 6931, 6948, 6949).
The Sprint ... [More >>]
July 17th, 2007. A new study published in the Annals of Internal Medicine finds that most type-2 diabetics are better off using older, cheaper diabetes drugs than their heavily advertised, newer counterparts. With the exception of those who cannot tolerate specific drugs like Glucophage (metformin), the effectiveness of the older medications was on ... [More >>]
June 29th, 2007. One million type two diabetics in the US, and nearly 6 million worldwide, who take Avandia (rosiglitazone maleate) may be putting themselves at an increased risk of heart attack.
Earlier this spring, The New England Journal of Medicine released a study by Dr. Steven Nissen that analyzed the combined results ... [More >>]
|

[site map] |